Navigation Links
2 Years of Hormone Use May Be 'Safe'
Date:2/3/2009

Cancer risk doesn't rise until third year, study finds

TUESDAY, Feb. 3 (HealthDay News) -- A potential two-year "safe period" for hormone replacement therapy has been identified by American Cancer Society epidemiologists, who also confirmed that using estrogen-plus-progesterone therapy increases the risk for both ductal and lobular breast cancer far more than taking estrogen alone.

The finding follows a report last month from the Society of Obstetricians and Gynaecologists of Canada that women have been needlessly scared away from using hormone therapy during menopause.

Researchers for the U.S. study followed 68,369 postmenopausal women who were cancer-free when the study began in 1992. They were followed through mid-2005.

Along with confirming previous findings of increased breast cancer risk from combination therapy, the research team also found that the cancer risk increases substantially within three years of starting estrogen-plus-progesterone therapy.

The risk for lobular cancer doubled after three years of estrogen-plus-progesterone use, and ductal cancer doubled in risk after 10 years of use, the study found.

With estrogen-only therapy, the likelihood of developing lobular cancer increased 50 percent after 10 years of use, but there was no increase in the risk for ductal cancer, even after 20 years.

However, the study found that women who used an estrogen-progesterone combination for less than two years had no increased risk, possibly representing a safe period for combination therapy, the researchers said.

Nor was added risk found for women who had used the hormone combination but had been off the therapy for two or more years.

The researchers said that this suggests a window of two to three years for the risks associated with the estrogen-plus-progesterone combination to become apparent after initial use and to diminish after the therapy is halted.

The study was expected to appear in the March issue of the journal Cancer and has been published online.

In the Canadian report, the doctors' group said that it was revising its guidelines for use of hormone replacement therapy, because evidence has shown that the drugs offer a safe and viable option for women experiencing troublesome menopause symptoms.

However, it was recommending that hormone therapy should start early in menopause and be used only short-term, according to an account in the Canadian Press.

In 2002, a large U.S. study found that menopausal hormone therapy increased the risk of heart attack and stroke. But, the Canadian experts said, that study incorrectly concluded that the increased risk seen in older women applied to all women who use the drugs.

More information

The U.S. National Cancer Institute has more about hormone therapy and cancer.



-- Robert Preidt



SOURCES: American Cancer Society, news release, Feb. 2, 2009; Jan. 22, 2009, Canadian Press


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Divorce, antidepressants, or weight gain/loss can add years to your face
2. Divorce, Antidepressants, or Weight Gain/Loss Can Add Years to Your Face
3. Cementless cup device developed for hip replacements shows durability after more than 20 years
4. DNA Solves Switched at Birth Mystery ... After 57 Years
5. After Eight Years of Injustice, International Family Planning Funding is Restored
6. Looking Years Younger, Raising a Few Brows
7. As New Administration Takes Office, Deloitte Report Identifies $530 Billion Savings Opportunity for Health Care Reform Over Next 10 Years
8. New drug development still takes 8 years despite faster FDA review, according to Tufts CSDD
9. Taking 20 Years Off Her Health and Looks, RealAge Member Flaunts It on Oprah Show
10. Max Muscle Sports Nutrition Offers $25,000 Reward For Your New Years Resolution
11. Miami Physician Sentenced to 30 Years in Prison for $11 Million Medicare Fraud Scheme
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
2  Years of Hormone Use May Be 'Safe'
(Date:6/25/2016)... ... ... Bruton Memorial Library on June 21 due to a possible lice infestation, as reported by ... lice: the parasite’s ability to live away from a human host, and to infest common ... the event that lice have simply gotten out of control. , As lice are a ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary ... Work award to iHire in recognition of their exemplary accomplishments in worksite health promotion. ... Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Marcy was in a crisis. Her son James, ... out at his family verbally and physically. , “When something upset him, he couldn’t control ... use it. He would throw rocks at my other children and say he was going ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, ... minimum wage raise to $12 an hour by 2020 and then adjusting it yearly to ... value of the minimum wage, assure the wage floor does not erode again, and make ...
(Date:6/24/2016)... Maryland (PRWEB) , ... June 24, 2016 , ... ... Angels is actively feeding the Frederick area economy by obtaining investment capital for ... over the past 2½ years that have already resulted in more than a ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... -- Research and Markets has announced the addition ... report to their offering. ... The World Market for Companion Diagnostics covers the world ... in the report includes the following: , ... by Region (N. America, EU, ROW), 2015-2020 , World ...
(Date:6/23/2016)... June 23, 2016  MedSource announced today that ... e-clinical software solution of choice.  This latest decision ... value to their clients by offering a state-of-the-art ... relationship establishes nowEDC as the EDC platform of ... full-service clients.  "nowEDC has long been a preferred ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
Breaking Medicine Technology: